{"summary":"Specialties: Finance and Accounting, Mergers & Acquisitions, Private Financings, Strategic Advice and Assistance, Board Membership, Valuations, Deal Structuring and Negotiation, Due Diligence, Financial Modeling and Analysis, Financial Restructuring, Leadership, Communication\n","lastName":"Scott","objectUrn":"urn:li:member:50889472","geoRegion":"San Diego, California, United States","fullName":"Kathy Scott","firstName":"Kathy","currentPositions":[{"companyName":"ARS Pharmaceuticals, Inc.","description":"ARS Pharmaceuticals is developing an intranasal epinephrine product for patients with type 1 severe allergic reactions. Kathy was deeply involved in a reverse merger with Silverback Therapeutics and is preparing for a commercial launch upon FDA approval anticipated in 2024.","title":"Chief Financial Officer","companyUrnResolutionResult":{"employeeCountRange":"11-50","headquarters":{"geographicArea":"California","country":"United States","city":"San Diego","postalCode":"92130","line2":"#130","line1":"11682 El Camino Real"},"website":"https:\/\/ars-pharma.com\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/arspharmaceuticals\/","industry":"Pharmaceutical Manufacturing"},"companyUrn":"urn:li:fs_salesCompany:19031898","tenureAtCompany":{"numYears":2,"numMonths":5},"startedOn":{"year":2022}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAMIgwABT85FsnpHa3IqpVjjUxPN2anFdVI,NAME_SEARCH,Tk5d)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1647812422976?e=1723075200&v=beta&t=Ia99SGzuIhCL8T3nM2dwS3ok2Ih8AA8UkKXwROFMZoY","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1647812422976?e=1723075200&v=beta&t=BbyL_fhEwRBZql-GsX_ZMys0QhjatZZDxL939AYetzM","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1647812422976?e=1723075200&v=beta&t=hw6uequWq5WCzjrsj8VKkBU0Rp5GFePl3lWFKCdGd5M","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1647812422977?e=1723075200&v=beta&t=FY1WO9Q_VjwTuihcD3sJtO_0JDxFFDTE1otBrWw-vZE","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C5603AQH2yto0l4awlQ\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{"websites":[{"$anti_abuse_annotations":[{"attributeId":97,"entityId":19,"sourceUrn":"urn:li:member:50889472"},{"attributeId":48,"entityId":19,"sourceUrn":"urn:li:member:50889472"}],"category":"COMPANY","dataSource":"LINKEDIN","url":"http:\/\/www.ars-pharma.com"}]},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":1991},"degree":"Bachelors","eduId":36077944,"schoolUrn":"urn:li:fs_salesSchool:2477","school":"urn:li:fs_salesSchool:2477","fieldsOfStudy":["Economics\/Business"],"startedOn":{"year":1987}}],"skills":[{"numOfEndorsement":15,"name":"Mergers"},{"numOfEndorsement":58,"name":"Valuation"},{"numOfEndorsement":20,"name":"Leadership"},{"numOfEndorsement":16,"name":"Restructuring"},{"numOfEndorsement":65,"name":"Due Diligence"},{"numOfEndorsement":30,"name":"Financial Modeling"},{"numOfEndorsement":81,"name":"Mergers & Acquisitions"},{"numOfEndorsement":26,"name":"Strategic Planning"},{"numOfEndorsement":23,"name":"Start-ups"},{"numOfEndorsement":9,"name":"Biotechnology"},{"numOfEndorsement":3,"name":"Private Equity"},{"numOfEndorsement":12,"name":"Business Strategy"},{"numOfEndorsement":14,"name":"Venture Capital"},{"numOfEndorsement":26,"name":"Executive Management"},{"numOfEndorsement":6,"name":"Corporate Governance"},{"numOfEndorsement":8,"name":"Entrepreneurship"},{"numOfEndorsement":5,"name":"Investments"},{"numOfEndorsement":4,"name":"Analysis"},{"numOfEndorsement":8,"name":"Management"},{"numOfEndorsement":12,"name":"Strategy"},{"numOfEndorsement":5,"name":"Auditing"},{"numOfEndorsement":1,"name":"Investment Banking"},{"numOfEndorsement":9,"name":"Accounting"},{"numOfEndorsement":6,"name":"Financial Structuring"},{"numOfEndorsement":1,"name":"Corporate Development"},{"numOfEndorsement":1,"name":"Divestitures"},{"numOfEndorsement":2,"name":"IPO"},{"numOfEndorsement":1,"name":"Private Placements"},{"numOfEndorsement":3,"name":"Equities"},{"numOfEndorsement":5,"name":"Risk Management"},{"numOfEndorsement":1,"name":"Cash Flow"},{"numOfEndorsement":3,"name":"SEC filings"},{"numOfEndorsement":1,"name":"Public Companies"},{"numOfEndorsement":8,"name":"Venture Financing"},{"numOfEndorsement":2,"name":"Acquisition Integration"},{"numOfEndorsement":1,"name":"Investor Relations"}],"numOfConnections":3474,"patents":[],"headline":"Chief Financial Officer for ARS Pharmaceuticals","courses":[],"certifications":[{"authority":"AICPA","name":"Certified Public Accountant","company":"urn:li:fs_salesCompany:8450","startedOn":{"year":1993},"companyUrn":"urn:li:fs_salesCompany:8450"},{"authority":"CFA Institute","name":"Chartered Financial Analyst (CFA)","company":"urn:li:fs_salesCompany:162977","startedOn":{"year":2002},"companyUrn":"urn:li:fs_salesCompany:162977"}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/kathleendscott","organizations":[{"name":"Corporate Directors Forum","position":"Board of Directors","startedOn":{"year":2010}},{"name":"AICPA","position":"Member"}],"location":"San Diego, California, United States","publications":[],"positions":null,"posts":[{"createdAt":1716921780000,"insightId":"9d6a3ead-3010-46ef-a101-5323b9a418bb","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D5622AQGed9YCk2V--g\/feedshare-shrink_2048_1536\/0\/1716921799097?e=1720051200&v=beta&t=s9ViAad49Bh_o2pyzdbtrF2ReEik77au-9R8kgmBHHU"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":33},{"type":"EMPATHY","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7201291975810039808","threadUrn":"urn:li:activity:7201291975810039808","reactionsCount":35,"commentsCount":3,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7201291974623051776","message":{"attributes":[{"start":3,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:ars"}}},{"start":116,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:anaphylaxis"}}},{"start":639,"length":14,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"http:\/\/ars-pharma.com"}}},{"start":657,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:allergy"}}},{"start":666,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:pharmajob"}}},{"start":677,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:pharmasales"}}},{"start":690,"length":6,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:sales"}}},{"start":697,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:specialtysales"}}},{"start":713,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:productlaunch"}}}],"text":"At #ARS Pharmaceuticals, Inc. we are innovating treatment for patients who suffer from allergic reactions including #anaphylaxis. Our mission is to develop treatments for patients and parents affected by severe allergic reactions that are safe and effective, needle-free, easy to carry, simple to administer and help eliminate the anxiety and hesitation associated with using an injectable device.\n\u00a0\nWe are currently hiring Specialty Sales Representatives throughout the country! Check out our openings and apply today: ARS Careers \n\u00a0\nTo learn more about ARS Pharmaceuticals, Inc. the exciting mission, and\ngroundbreaking innovation visit\u00a0ars-pharma.com \n\u00a0\n#allergy #pharmajob\n#pharmasales\n#sales #specialtysales #productlaunch \n"},"entityUrn":"urn:li:share:7201291974623051776"}}},{"createdAt":1713570180000,"insightId":"0e485897-9cb1-42fa-8985-9eaacffcf19d","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":5}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7187234392052793344","threadUrn":"urn:li:activity:7187234392052793344","reactionsCount":5,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7187234391482331136","message":{"attributes":[{"start":0,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/grcwdQU9"}}}],"text":"https:\/\/lnkd.in\/grcwdQU9"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4D22AQEDlrfPRtWTKw\/feedshare-shrink_2048_1536\/0\/1712267416117?e=1720051200&v=beta&t=6WtjdOW_rk43_AxJ1RGQncXtDtfCq_bP8onvy2rPyfs"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7181770074137968641","message":{"attributes":[{"start":375,"length":22,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/bit.ly\/3vkv9XP"}}},{"start":405,"length":17,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:boardofdirectors"}}},{"start":423,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:directorsforum"}}},{"start":439,"length":19,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:elevatedleadership"}}},{"start":459,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:networking"}}},{"start":471,"length":17,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:sandiegobusiness"}}},{"start":489,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:sandiegolocal"}}},{"start":504,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:sandiegoevents"}}},{"start":520,"length":25,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:sandiegonetworkingevents"}}},{"start":546,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:directoroftheyear"}}}],"text":"Nominations are now open for Director of the Year. Each year, Corporate Directors Forum honors San Diego\u2019s top directors. \n\nThe purpose of the award is to pay tribute to their outstanding performance in the boardroom and behind the scenes and recognize their extraordinary contributions in various award categories. \n\nNomination deadline is Wednesday, May 1, 2024 @ 5 pm PT: https:\/\/bit.ly\/3vkv9XP \n.\n.\n.\n#boardofdirectors #directorsforum #elevatedleadership #networking #sandiegobusiness #sandiegolocal #sandiegoevents #sandiegonetworkingevents #directoroftheyear"},"entityUrn":"urn:li:share:7181770074137968641"},"entityUrn":"urn:li:share:7187234391482331136"}}},{"createdAt":1713154560000,"insightId":"b71783e2-357e-43bb-b9ed-ed287f0ba383","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7184251858482348033,7185491228828807168)","threadUrn":"urn:li:activity:7184251858482348033","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"You are amazing Kayla.  It was a pleasure to work with you for many years.  Congratulations!  You are truly a gem. "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7184251858482348033"}}}]}